Summit Trail Advisors’s Axogen AXGN Stock Holding History

Summit Trail Advisors’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,404	Closed	-$71K	–	287
2018 Q2	$71K	Buy	+1,404	New	+$61.9K	0.02%	264

Other funds holding AXGN

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Summit Trail Advisors's AXGN Position: Q3 2018 in Review

Summit Trail Advisors sold out of Axogen (AXGN) in Q3 2018, closing a stake of 1,404 shares — an estimated $71K sold.

Summit Trail Advisors first reported a position in AXGN in Q2 2018 and held it in 1 quarter. The position peaked at $71K in Q2 2018. 162 funds tracked by Wall St. Rank hold AXGN as of Q3 2018.

Summit Trail Advisors reported no remaining Axogen position as of Q3 2018 after selling out during the quarter.
Summit Trail Advisors sold 1,404 Axogen shares in Q3 2018, an estimated $71K.
Summit Trail Advisors first reported a position in Axogen in Q2 2018 and held it in 1 quarter.
Summit Trail Advisors's Axogen position peaked at $71K in Q2 2018.
162 funds tracked by Wall St. Rank held Axogen as of Q3 2018.

Based on Summit Trail Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.